التفاصيل البيبلوغرافية
| العنوان: |
Chronic Rhinosinusitis: Risk Factors for the Recurrence of Chronic Rhinosinusitis Based on 5-Year Follow-Up after Endoscopic Sinus Surgery. |
| المؤلفون: |
Matsuwaki, Yoshinori, Ookushi, Tetsushi, Asaka, Daiya, Mori, Eri, Nakajima, Tsuneya, Yoshida, Takuto, Kojima, Junya, Chiba, Shintaro, Ootori, Nobuyoshi, Moriyama, Hiroshi |
| المصدر: |
International Archives of Allergy & Immunology; 2008 Supplement 1, Vol. 146, p77-81, 5p, 2 Charts |
| مصطلحات موضوعية: |
SINUSITIS, DISEASE risk factors, IMMUNOLOGY, ANTI-inflammatory agents, EOSINOPHILS |
| مصطلحات جغرافية: |
UNITED States |
| مستخلص: |
Background: Chronic rhinosinusitis (CRS) is one of the most frequent chronic diseases in the US, and little is understood about its pathogenesis. This study was conducted to characterize, retrospectively, the clinical, objective and immunological parameters that accompany recurrence of CRS during long-term follow-up after surgery. Methods: Fifty-six patients with CRS who had undergone endoscopic sinus surgery were followed up for 5 years after the surgery. The CRS parameters chosen were as follows: history of asthma and/or allergic rhinitis, peripheral eosinophilia of at least 520 cells/μl, peripheral eosinophil count, total IgE, presence of polyps, CT score, presence of fungi (positive fungal culture or stain), mucus or mucosal eosinophilia, mucosal eosinophil count, presence of acute infection after surgery, gender and age. Individual correlations and stepwise regression were performed. Results: Patients with a total peripheral eosinophil count of 520/μl or more and those with asthma were likely to experience recurrence of CRS within 5 years after surgery. Furthermore, patients with mucus or mucosal eosinophilia who were diagnosed as having eosinophilic CRS (ECRS) showed a high incidence of recurrence within 5 years. The parameter of mucus or mucosal eosinophilia (diagnosis of ECRS) had a positive predictive value of 85.7%. Conclusions: Surgeons should always examine the inflammatory infiltrate of nasal polyps or the paranasal mucosa, and patients with ECRS require anti-inflammatory medications, such as steroids, for a long time after surgery. Long-term follow-up is also essential. Copyright © 2008 S. Karger AG, Basel [ABSTRACT FROM AUTHOR] |
|
Copyright of International Archives of Allergy & Immunology is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
